In the pharmaceutical industry, Nystatin 100,000 IU Vaginal Tablets (also known as inserts) are specialized polyene antifungals. As a pharmacist and manufacturer, I view the administration of this product as a Targeted Local Therapy; because Nystatin is not absorbed through the mucous membranes into the bloodstream, its efficacy depends entirely on proper physical placement and consistent contact with the vaginal wall.

At your WHO-GMP facility in Mumbai, ensuring clear “Instructions for Use” (IFU) is a vital technical value-add for your B2B gynecological and hospital-supply portfolios.

Therapeutic Profile: Optimal Administration

Step	Recommended Protocol	Technical Rationale
Timing	Bedtime (QHS)	Lying down minimizes drug leakage, ensuring the tablet remains in contact with the vaginal mucosa for the maximum duration.
Preparation	Moisten the tablet	Lightly dipping the tablet in water before insertion helps it dissolve more effectively in the vaginal environment.
Placement	High Vaginal Cavity	The tablet must be deposited as deep as comfortably possible to target the primary site of Candida colonization.
Duration	14 Consecutive Days	Even if symptoms disappear in 48 hours, the full course is technically required to prevent recurrence.

Step-by-Step Insertion Guide

Preparation: Wash your hands thoroughly. Remove the tablet from the foil/strip and place it into the end of the provided applicator.

Positioning: Lie on your back with your knees drawn up toward your chest (lithotomy position).

Insertion: Gently insert the applicator into the vagina as far as it will comfortably go.

Deployment: Push the plunger to release the tablet. Remove the applicator and wash it with warm, soapy water immediately.

Hygiene: Wash your hands again to prevent the spread of the fungal infection.

Mechanism: Sterol Binding and Pore Formation

Nystatin works through a physical-chemical disruption of the fungal cell:

Sterol Affinity: It has a high affinity for Ergosterol, a key component of the fungal cell membrane (but absent in human cell membranes).

Pore Formation: Once bound to ergosterol, Nystatin molecules aggregate to form transmembrane pores or channels.

Lethal Leakage: These pores allow essential intracellular components (like Potassium ions and small molecules) to leak out of the fungus.

Fungicidal Action: This rapid loss of internal pressure and nutrients leads to the “death by leakage” of the Candida species.

The Pharmacist’s “Technical Warning”

• The “Menstruation” Rule: Do not stop treatment during your period. Use sanitary napkins rather than tampons, as tampons will absorb the medication and reduce its efficacy.

• Contraceptive Risk: Critical B2B Note: Some Nystatin formulations may contain oils or excipients that can damage latex condoms and diaphragms. Advise patients to use non-latex alternatives or avoid intercourse during treatment.

• Pregnancy Precaution: In your WHO-GMP product literature, note that while Nystatin is safe (Category A), applicators should be used with extreme caution during pregnancy to avoid cervical trauma; manual insertion may be preferred.

• Staining: Nystatin can leave a yellowish residue. Wearing a pantyliner protects clothing and maintains patient comfort.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

• The “Heat-Stable” USP: On your digital marketplace, highlight that your Nystatin tablets are formulated to remain stable at Zone IVb temperatures (up to 30°C). This is a major selling point for export to tropical regions compared to suppositories that melt.

• Packaging Integrity: Nystatin is light-sensitive. Utilizing Alu-Alu blister packaging is the industry standard for ensuring a 36-month shelf life.

• Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers to support your firm’s registration in international tenders for maternal and reproductive health.